Medicine
Travoprost Ophthalmic Soluton 0.04 mg/mL eye drops
Travoprost Ophthalmic Soluton 0.04 mg/mL eye drops is a prescription medicine containing Travoprost for ophthalmic use, marketed by Sagent Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2° to 25°C (36° to 77°F).
Key facts
- Active ingredient (INN)
- Travoprost
- Brand
- Travoprost Ophthalmic Soluton
- Strength
- 0.04 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle
- Marketing authorisation holder
- Sagent Pharmaceuticals
- Manufacturer
- Sagent Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 2° to 25°C (36° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE04 Travoprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 July 2025
- Identifiers
- RxCUI 284008DailyMed set ID 498a376e-a74e-48d8-a022-ad15a1ecadb5NDC 25021-002Application ANDA218159
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 25021-002-02 | Sagent Pharmaceuticals | 15 July 2025 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 25021-002-05 | Sagent Pharmaceuticals | 15 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Travoprost 0.04 mg/mL eye drops.
Other strengths and forms of Travoprost
Clinical summary
Travoprost is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops, ophthalmic solution and implants for intracameral use. MedsAcross supplies Travoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TravoprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Travatan Z prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
- Izba: European public assessment report (EPAR) · European Medicines Agency
- Travatan: European public assessment report (EPAR) · European Medicines Agency
Need Travoprost Ophthalmic Soluton 0.04 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.